Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6648272 | 0.86 | ALDH1A1 (0.47) | MAPTLMNA | |
| SCHEMBL6650639 | 0.79 | POLB (0.39) | MAPTHRH3CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL6650689 | 0.78 | L3MBTL1 (0.40) | MAPTCYP1A2CYP2D6CYP2C19LMNA | |
| SCHEMBL5599579 | 0.76 | PSMB1 (0.37) | HRH3CYP1A2 | |
| SCHEMBL6654163 | 0.73 | HRH3 (0.35) | MAPTHRH3CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL5599453 | 0.71 | HRH3 (0.43) | HRH3 | |
| SCHEMBL6650163 | 0.71 | PSEN1 (0.38) | MAPTHRH3CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL6650451 | 0.70 | LMNA (0.39) | HRH3CYP1A2CYP2D6CYP2C19LMNA | |
| SCHEMBL5599833 | 0.69 | HRH3 (0.39) | HRH3 | |
| SCHEMBL6648700 | 0.68 | HRH3 (0.35) | HRH3CYP1A2CYP2D6CYP2C19ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1103243-B1 | UTILIZATION OF ARYL(OR HETEROARYL)AZOLYLCARBINOL DERIVATIVES FOR THE TREATMENT OF TROUBLES MEDIATED BY AN EXCESS OF SUBSTANCE P | ESTEVE LABOR DR (ES) | 2004-01-07 | — | — | EP | claimed |